Author
Mark S. Freedman
Also Known As
M.S. Freedman, Mark Freedman, Mark S Freedman, Mark S. Freedman, Mark Steven Freedman
47
Publications
2.3K
Citations
19
H-Index
45
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 12 | 13 | 1.7K |
2 | Natural Sciences | 1 | 1 | 43 |
3 | Social Sciences | 1 | 1 | 51 |
4 | Allergy | 1 | 1 | 404 |
5 | Biochemistry | 1 | 1 | 43 |
Mark S. Freedman
×
17
Publications
1.6K
Citations
15
H-Index
| Year | Citations | |
|---|---|---|
2007 | 404 | |
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension Raju Kapoor, Pei‐Ran Ho, Nolan Campbell, Disease ProgressionNeurological DisorderImmunologyClinical TrialsNeurology | 2018 | 327 |
2013 | 230 | |
1991 | 130 | |
2007 | 101 | |
1994 | 71 | |
1992 | 60 | |
1998 | 56 | |
1997 | 51 | |
1990 | 48 |
Page 1
Page 1